168 related articles for article (PubMed ID: 9918119)
21. CIS3/SOCS-3 suppresses erythropoietin (EPO) signaling by binding the EPO receptor and JAK2.
Sasaki A; Yasukawa H; Shouda T; Kitamura T; Dikic I; Yoshimura A
J Biol Chem; 2000 Sep; 275(38):29338-47. PubMed ID: 10882725
[TBL] [Abstract][Full Text] [Related]
22. The central role of SOCS-3 in integrating the neuro-immunoendocrine interface.
Auernhammer CJ; Melmed S
J Clin Invest; 2001 Dec; 108(12):1735-40. PubMed ID: 11748254
[No Abstract] [Full Text] [Related]
23. Interplay between the cardiac renin angiotensin system and JAK-STAT signaling: role in cardiac hypertrophy, ischemia/reperfusion dysfunction, and heart failure.
Booz GW; Day JN; Baker KM
J Mol Cell Cardiol; 2002 Nov; 34(11):1443-53. PubMed ID: 12431443
[TBL] [Abstract][Full Text] [Related]
24. Identification of critical residues required for suppressor of cytokine signaling-specific regulation of interleukin-4 signaling.
Haque SJ; Harbor PC; Williams BR
J Biol Chem; 2000 Aug; 275(34):26500-6. PubMed ID: 10950967
[TBL] [Abstract][Full Text] [Related]
25. The Jak-STAT pathway.
Imada K; Leonard WJ
Mol Immunol; 2000; 37(1-2):1-11. PubMed ID: 10781830
[TBL] [Abstract][Full Text] [Related]
26. Curcumin suppresses Janus kinase-STAT inflammatory signaling through activation of Src homology 2 domain-containing tyrosine phosphatase 2 in brain microglia.
Kim HY; Park EJ; Joe EH; Jou I
J Immunol; 2003 Dec; 171(11):6072-9. PubMed ID: 14634121
[TBL] [Abstract][Full Text] [Related]
27. Cytokine-inducible SH2-containing protein suppresses PRL signaling by binding the PRL receptor.
Dif F; Saunier E; Demeneix B; Kelly PA; Edery M
Endocrinology; 2001 Dec; 142(12):5286-93. PubMed ID: 11713228
[TBL] [Abstract][Full Text] [Related]
28. Three distinct domains of SSI-1/SOCS-1/JAB protein are required for its suppression of interleukin 6 signaling.
Narazaki M; Fujimoto M; Matsumoto T; Morita Y; Saito H; Kajita T; Yoshizaki K; Naka T; Kishimoto T
Proc Natl Acad Sci U S A; 1998 Oct; 95(22):13130-4. PubMed ID: 9789053
[TBL] [Abstract][Full Text] [Related]
29. Interleukin 9 induces expression of three cytokine signal inhibitors: cytokine-inducible SH2-containing protein, suppressor of cytokine signalling (SOCS)-2 and SOCS-3, but only SOCS-3 overexpression suppresses interleukin 9 signalling.
Lejeune D; Demoulin JB; Renauld JC
Biochem J; 2001 Jan; 353(Pt 1):109-116. PubMed ID: 11115404
[TBL] [Abstract][Full Text] [Related]
30. CIS3 and JAB have different regulatory roles in interleukin-6 mediated differentiation and STAT3 activation in M1 leukemia cells.
Suzuki R; Sakamoto H; Yasukawa H; Masuhara M; Wakioka T; Sasaki A; Yuge K; Komiya S; Inoue A; Yoshimura A
Oncogene; 1998 Oct; 17(17):2271-8. PubMed ID: 9811457
[TBL] [Abstract][Full Text] [Related]
31. A mutant form of JAB/SOCS1 augments the cytokine-induced JAK/STAT pathway by accelerating degradation of wild-type JAB/CIS family proteins through the SOCS-box.
Hanada T; Yoshida T; Kinjyo I; Minoguchi S; Yasukawa H; Kato S; Mimata H; Nomura Y; Seki Y; Kubo M; Yoshimura A
J Biol Chem; 2001 Nov; 276(44):40746-54. PubMed ID: 11522790
[TBL] [Abstract][Full Text] [Related]
32. JAK/STAT-dependent gene regulation by cytokines.
Hebenstreit D; Horejs-Hoeck J; Duschl A
Drug News Perspect; 2005 May; 18(4):243-9. PubMed ID: 16034480
[TBL] [Abstract][Full Text] [Related]
33. Role of Jak kinases and STATs in cytokine signal transduction.
Leonard WJ
Int J Hematol; 2001 Apr; 73(3):271-7. PubMed ID: 11345192
[TBL] [Abstract][Full Text] [Related]
34. CIS3/SOCS3/SSI3 plays a negative regulatory role in STAT3 activation and intestinal inflammation.
Suzuki A; Hanada T; Mitsuyama K; Yoshida T; Kamizono S; Hoshino T; Kubo M; Yamashita A; Okabe M; Takeda K; Akira S; Matsumoto S; Toyonaga A; Sata M; Yoshimura A
J Exp Med; 2001 Feb; 193(4):471-81. PubMed ID: 11181699
[TBL] [Abstract][Full Text] [Related]
35. Cytokines and STAT signaling.
Schindler C; Strehlow I
Adv Pharmacol; 2000; 47():113-74. PubMed ID: 10582086
[No Abstract] [Full Text] [Related]
36. The suppressors of cytokine signalling (SOCS).
Kile BT; Alexander WS
Cell Mol Life Sci; 2001 Oct; 58(11):1627-35. PubMed ID: 11706989
[TBL] [Abstract][Full Text] [Related]
37. Mutational analyses of the SOCS proteins suggest a dual domain requirement but distinct mechanisms for inhibition of LIF and IL-6 signal transduction.
Nicholson SE; Willson TA; Farley A; Starr R; Zhang JG; Baca M; Alexander WS; Metcalf D; Hilton DJ; Nicola NA
EMBO J; 1999 Jan; 18(2):375-85. PubMed ID: 9889194
[TBL] [Abstract][Full Text] [Related]
38. Mechanism of inhibition of growth hormone receptor signaling by suppressor of cytokine signaling proteins.
Hansen JA; Lindberg K; Hilton DJ; Nielsen JH; Billestrup N
Mol Endocrinol; 1999 Nov; 13(11):1832-43. PubMed ID: 10551777
[TBL] [Abstract][Full Text] [Related]
39. SOCS-1, -2, -3: selective targets and functions downstream of the prolactin receptor.
Tomic S; Chughtai N; Ali S
Mol Cell Endocrinol; 1999 Dec; 158(1-2):45-54. PubMed ID: 10630404
[TBL] [Abstract][Full Text] [Related]
40. Janus kinases (JAKs) and signal transducers and activators of transcription (STATs) in hematopoietic cells.
Nosaka T; Kitamura T
Int J Hematol; 2000 Jun; 71(4):309-19. PubMed ID: 10905049
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]